Finance

Lists
600721:SHA
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
CNÂ¥10.91
-4.30%
(-0.49) 1D
Sep 11, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600721...
Open
CNÂ¥11.08
High
CNÂ¥11.60
Low
CNÂ¥10.65
Mkt. cap
4.38B
Avg. vol.
103.02M
Volume
82.84M
Dividend
0.37%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 8, 2026
P/E ratio
139.94
52-wk high
CNÂ¥16.68
52-wk low
CNÂ¥6.25
EPS
CNÂ¥0.08
Shares outstanding
400.39M
No. of employees
672
Open
CNÂ¥11.08
High
CNÂ¥11.60
Low
CNÂ¥10.65
Mkt. cap
4.38B
Avg. vol.
103.02M
Volume
82.84M
Dividend
0.37%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 8, 2026
P/E ratio
139.94
52-wk high
CNÂ¥16.68
52-wk low
CNÂ¥6.25
EPS
CNÂ¥0.08
Shares outstanding
400.39M
No. of employees
672
About Xinjiang Bai Hua Cun Pharma Tech Co Ltd
CEO-
Employees672
Founded1959
Headquarters-
SectorPharmaceutical industry
Websitexjbhc.net
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
96.52M
89.71M
67.18M
90.17M
Cost of goods sold
37.13M
85.29M
34.92M
50.32M
Cost of revenue
37.13M
85.29M
34.92M
50.32M
Research and development expenses
5.91M
6.30M
4.03M
5.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.01M
14.60M
15.21M
17.58M
Operating expense
25.37M
16.82M
22.87M
21.10M
Total operating expenses
62.51M
102.11M
57.80M
71.42M
Operating income
34.01M
-12.40M
9.38M
18.75M
Other non operating income
96.03K
-19.62K
-14.06K
-6.18M
EBT including unusual items
8.17M
5.44M
7.26M
9.45M
EBT excluding unusual items
34.94M
-14.36M
10.38M
13.01M
Income tax expense
978.65K
-2.57M
620.69K
1.34M
Effective tax rate
11.98%
-47.26%
8.55%
14.14%
Other operating expenses
1.32M
1.44M
1.40M
522.33K
Net income
7.19M
8.01M
6.64M
8.12M
Net profit margin
7.45%
8.93%
9.89%
9.00%
Earnings per share
-
-
-
-
Interest and investment income
834.46K
-
1.09M
446.02K
Interest expense
-
-1.88M
-79.79K
-
Net interest expenses
834.46K
-1.88M
1.01M
446.02K
Depreciation and amortization charges
-
-
-
-
EBITDA
38.42M
-7.94M
13.84M
23.49M
Gain or loss from assets sale
-
-884.00
-
-
AI content may include mistakes. Learn more
Google apps